Show simple item record

dc.contributor.authorRomero-Ortuno, Roman
dc.contributor.authorO’Connell, Matthew DL
dc.contributor.authorFinucane, Ciaran
dc.contributor.authorSoraghan, Christopher
dc.contributor.authorFan, Chie W
dc.contributor.authorKenny, Rose A
dc.date.accessioned2013-07-19T10:59:39Z
dc.date.available2013-07-19T10:59:39Z
dc.date.issued2013-07-15
dc.identifier.citationBMC Geriatrics. 2013 Jul 15;13(1):73
dc.identifier.urihttp://dx.doi.org/10.1186/1471-2318-13-73
dc.identifier.urihttp://hdl.handle.net/10147/296541
dc.description.abstractAbstract Background Our previously proposed morphological classification of orthostatic hypotension (MOH) is an approach to the definition of three typical orthostatic hemodynamic patterns using non-invasive beat-to-beat monitoring. In particular, the MOH pattern of large drop/non-recovery (MOH-3) resembles the syndrome of supine hypertension–orthostatic hypotension (SH-OH), which is a treatment challenge for clinicians. The aim of this study was to characterise MOH-3 in the first wave of The Irish Longitudinal Study of Ageing (TILDA), with particular attention to concurrent symptoms of orthostatic intolerance (OI), prescribed medications and association with history of faints and blackouts. Methods The study included all TILDA wave 1 participants who had a Finometer® active stand. Automatic data signal checks were carried out to ensure that active stand data were of sufficient quality. Characterisation variables included demographics, cardiovascular and neurological medications (WHO-ATC), and self-reported information on comorbidities and disability. Multivariable statistics consisted of logistic regression models. Results Of the 4,467 cases, 1,456 (33%) were assigned to MOH-1 (small drop, overshoot), 2,230 (50%) to MOH-2 (medium drop, slower but full recovery), and 781 (18%) to MOH-3 (large drop, non-recovery). In the logistic regression model to predict MOH-3, statistically significant factors included being on antidepressants (OR = 1.99, 95% CI: 1.50 – 2.64, P < 0.001) and beta blockers (OR = 1.60, 95% CI: 1.26 – 2.04, P < 0.001). MOH-3 was an independent predictor of OI after full adjustment (OR = 1.47, 95% CI: 1.25 – 1.73, P < 0.001), together with being on hypnotics or sedatives (OR = 1.83, 95% CI: 1.31 – 2.54, P < 0.001). In addition, OI was an independent predictor of history of falls/blackouts after full adjustment (OR = 1.27, 95% CI: 1.09 – 1.48, P = 0.003). Conclusions Antidepressants and beta blockers were independently associated with MOH-3, and should be used judiciously in older patients with SH-OH. Hypnotics and sedatives may add to the OI effect of MOH-3. Several trials have demonstrated the benefits of treating older hypertensive patients with cardiovascular medications that were not associated with adverse outcomes in our study. Therefore, the evidence of benefit does not necessarily have to conflict with the evidence of potential harm.
dc.titleInsights into the clinical management of the syndrome of supine hypertension ¿ orthostatic hypotension (SH-OH): The Irish Longitudinal Study on Ageing (TILDA)
dc.typeJournal Article
dc.language.rfc3066en
dc.rights.holderRoman Romero-Ortuno et al.; licensee BioMed Central Ltd.
dc.description.statusPeer Reviewed
dc.date.updated2013-07-19T00:14:57Z
refterms.dateFOA2018-08-23T06:24:03Z
html.description.abstractAbstract Background Our previously proposed morphological classification of orthostatic hypotension (MOH) is an approach to the definition of three typical orthostatic hemodynamic patterns using non-invasive beat-to-beat monitoring. In particular, the MOH pattern of large drop/non-recovery (MOH-3) resembles the syndrome of supine hypertension&#8211;orthostatic hypotension (SH-OH), which is a treatment challenge for clinicians. The aim of this study was to characterise MOH-3 in the first wave of The Irish Longitudinal Study of Ageing (TILDA), with particular attention to concurrent symptoms of orthostatic intolerance (OI), prescribed medications and association with history of faints and blackouts. Methods The study included all TILDA wave 1 participants who had a Finometer&#174; active stand. Automatic data signal checks were carried out to ensure that active stand data were of sufficient quality. Characterisation variables included demographics, cardiovascular and neurological medications (WHO-ATC), and self-reported information on comorbidities and disability. Multivariable statistics consisted of logistic regression models. Results Of the 4,467 cases, 1,456 (33%) were assigned to MOH-1 (small drop, overshoot), 2,230 (50%) to MOH-2 (medium drop, slower but full recovery), and 781 (18%) to MOH-3 (large drop, non-recovery). In the logistic regression model to predict MOH-3, statistically significant factors included being on antidepressants (OR = 1.99, 95% CI: 1.50 &#8211; 2.64, P &lt; 0.001) and beta blockers (OR = 1.60, 95% CI: 1.26 &#8211; 2.04, P &lt; 0.001). MOH-3 was an independent predictor of OI after full adjustment (OR = 1.47, 95% CI: 1.25 &#8211; 1.73, P &lt; 0.001), together with being on hypnotics or sedatives (OR = 1.83, 95% CI: 1.31 &#8211; 2.54, P &lt; 0.001). In addition, OI was an independent predictor of history of falls/blackouts after full adjustment (OR = 1.27, 95% CI: 1.09 &#8211; 1.48, P = 0.003). Conclusions Antidepressants and beta blockers were independently associated with MOH-3, and should be used judiciously in older patients with SH-OH. Hypnotics and sedatives may add to the OI effect of MOH-3. Several trials have demonstrated the benefits of treating older hypertensive patients with cardiovascular medications that were not associated with adverse outcomes in our study. Therefore, the evidence of benefit does not necessarily have to conflict with the evidence of potential harm.


Files in this item

Thumbnail
Name:
1471-2318-13-73.xml
Size:
159.9Kb
Format:
XML
Thumbnail
Name:
1471-2318-13-73.pdf
Size:
624.6Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record